This talk was presented at the 2018 SAGES Meeting/16th World Congress of Endoscopic Surgery by Andrew S Kastenmeier during the Surgical Options in Gastroparesis on April 11 2018
Keyword(s): antrum, central nervous system, CNS, complications, contraction, cost-effective, device, diabetic, diabetics, diagnosis, E.D., emergency department, energy device, enteral nutrition, Enterra therapy, FDA, fMRI, Food & Drug Administration, functional MRI, gastric electrical stimulation therapy, gastric emptying, gastric motility, gastric pacemaker, gastroparesis, general anesthesia, GES, glycemic control, greater curve, gut hormones, HbA1c, HDE, health related quality of life, healthcare costs, HRQOL, Humanitarian Device Exemption, idiopathic, ileus, implantation, indications, intractable nausea, medical management, medical refractory gastroparesis, myenteric plexus, narcotics, neurostimulation, open label, pain, pain control, parenteral nutrition, peristalsis, PET scan, pharmacotherapy, placebo effect, pyloric, pylorus, reoperation, resource utilization, risks, stimulator, stomach, treatment failure, upper endoscopy, vagal afferents, vomiting
Citation–6:37 Gastroenterology 2003
Clin Gastroenterol Hepatol 2010
J Neurogastroenterol Motil 2017
Clin Gastroenterol Hepatol 2011
Complications & reoperations–11:43 Auton Neurosci 2017
Factors predictive of favorable response–12:02 Auton Neurosci 2017